Zoiko Healthcare is a global life sciences and medical innovation enterprise committed to transforming how healthcare is developed, accessed, and delivered. Headquartered in the United States with strategic operations across the United Kingdom, Africa, and Asia-Pacific, we bring a world-class portfolio of products and platforms to both developed and underserved markets.
Founded by Lennox McLeod, a global business leader with deep expertise in cross-border healthcare strategy, Zoiko Healthcare was built on the philosophy that access to quality care is a right — not a privilege. Our enterprise champions affordability, inclusion, and innovation at every level of the healthcare value chain.
Our business spans four high-growth divisions: Pharmaceuticals, Medical Technology, Nutraceuticals, and Dermatological Science. We serve public health institutions, private hospitals, specialty clinics, and cross-border distributors with solutions that meet international quality and regulatory standards.
Zoiko Healthcare prioritizes high-burden therapeutic areas: Oncology, Cardiology, Diabetology, Pain Management, and Respiratory Treatment. We also lead in Nutraceutical Therapeutics and Dermatological Solutions through our subsidiaries Supremo Nutrition, Dermisque, and Kallyv.
Our robust clinical pipeline and R&D investments span next-generation formulations, fixed-dose combinations, biosimilars, and digital healthcare platforms. We collaborate with CROs, universities, and biotech firms across the USA, UK, India, and Africa — using an open innovation framework that accelerates delivery to market.
From AI-powered diagnostics and smart medication tracking to reformulated treatments for emerging markets, Zoiko Healthcare is advancing future-ready, scalable solutions.
Our robust clinical pipeline and R&D investments span next-generation formulations, fixed-dose combinations, biosimilars, and digital healthcare platforms. We collaborate with CROs, universities, and biotech firms across the USA, UK, India, and Africa — using an open innovation framework that accelerates delivery to market.
From AI-powered diagnostics and smart medication tracking to reformulated treatments for emerging markets, Zoiko Healthcare is advancing future-ready, scalable solutions.
Supporting national formularies, medicine access, and strategic procurement.
Offering ready-to-scale branded and white-label product lines.
Providing access to a high-growth global healthcare platform with ESG-led performance.
Zoiko Healthcare is governed by a high-integrity leadership team and independent board. Our ESG framework includes sustainable sourcing, carbon accountability, and community-first engagement across all operational regions. We actively promote women in science, ethical business practices, and capacity-building in emerging economies.
We welcome partnerships across the value chain — from research and clinical trials to distribution, licensing, and investment. We invite you to connect at:
